Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 947 results for "daiichi sankyo"

Zenotech Labs to be referred to BIFR
Business Standard

Zenotech Labs to be referred to BIFR

Sun Pharma, Daiichi Sankyo together hold 66.85% shares of the company BS Reporter May 26, 2015 Last Updated at 20:30 IST The board of directors of Hyderabad-based Zenotech Laboratories Limited, which is now in the hands of Sun Pharmaceutical Industries ... Business Standard, 4 days ago
Daiichi Sankyo Sells Shares Of Sun Pharma Asian Scientist, 3 weeks ago

83 images for daiichi sankyo

Review Seeker, 3 weeks ago
PR Newswire, 3 weeks ago
Business Today India, 1 month ago
Business Today India, 1 month ago
Deccan Chronicle, 1 month ago
NDTV Profit, 1 month ago
Bio Spectrum Asia, 1 month ago
MDLinx, 1 week ago
NDTV Profit, 1 month ago
Financial Express, 1 month ago

Daiichi Sankyo to market influenza HA vaccine Kaketsuken

Daiichi Sankyo Company, Limited has signed a cooperative sales agreement with The Chemo-Sero-Therapeutic Research Institute (Kaketsuken) for its influenza HA vaccine Kaketsuken. The Kaketsuken is an egg-based, inactivated vaccine used for ...
 PharmaBiz1 week ago Daiichi Sankyo Announces Cooperative Sales Agreement for the Influenza HA Vaccine Kaketsuken  Noodls1 week ago DAIICHI SANKYO : Announces Determination of Matters Relating to Acquisition of Treasury Shares  4 Traders2 weeks ago Daiichi Sankyo : Announces Dividend Forecasts for Fiscal 2015 (Commemorative Dividend to Mark 10th Anniversary)  4 Traders2 weeks ago
India Infoline

Japan's Daiichi Sankyo still on the hook for Ranbaxy bills?

Think Daiichi Sankyo set itself free of Ranbaxy Laboratories when it sold its stock in Sun Pharmaceutical? Think again. It remains possibly liable until 2022 for another $325 million as the Ranbaxy mess is cleaned up in the United States. The ...
 Fierce Drug Delivery2 weeks ago Daiichi Sankyo's India exit, a Credit Positive  India Infoline1 month ago Sun Pharma tanks 11% on Daiichi exit  Times of India1 month ago Sun Pharma Slumps Over 10% as Daiichi Exits  NDTV1 month ago

BSE gains over 100 points as markets regain some ground

Sun Pharma, which lost over 10% of its value on Tuesday after Daiichi Sankyo announced exiting the company by selling all its shares, gained over 2% on the NSE in morning trade.
 DNA1 month ago Sun Pharma stock tank 11% as Daiichi makes a dash for exit  DNA1 month ago Daiichi Sankyo decides to exit Sun Pharma stock  DNA1 month ago

For Daiichi, side effects of Ranbaxy refuse to wane

Daiichi Sankyo divested its Ranbaxy unit last month Ranbaxy, seven years after making the acquisition, but a clause may hold the Japanese drugmaker liable for penalty payouts a total of $325 million for that time period, reported The Financial ...
 FirstWord Pharma1 week ago
India Infoline

Sun Pharma shares bounce back, up 3 pc on bourses

made a comeback at the bourses today, rising nearly 3 per cent, a day after Japanese drugmaker Daiichi Sankyo sold its entire stake of around 9 per cent in the company for Rs 20,025 crore. After making a positive opening, shares of the company further gained ...
 Business Standard1 month ago Daiichi deal blows 11% off Sun Pharma stock price  The Financial Chronicle1 month ago Sun Pharma slumps 9% on Daiichi exit  India Infoline1 month ago Sun dips nearly 9%;top loser on Sensex, Nifty as Daiichi exits  Business Standard1 month ago

Daiichi Sankyo's $3.6 billion exit from Sun Pharma hits rupee, stocks

fell to a three-and-a-half month low on Tuesday and stocks sank to their lowest in nearly four weeks on concerns about foreign outflows after Japan's Daiichi Sankyo's $3.6 billon share sale in Sun Pharmaceutical Industries. Daiichi Sankyo began the sale late ...
 Economic Times1 month ago Daiichi's exit from Sun Pharma hits rupee, stocks  Sify1 month ago

Daiichi Sankyo sells Sun Pharma stake in block deals; stock plunges

By ECONOMICTIMES.COM | 21 Apr, 2015, 09.47AM IST Post a Comment MUMBAI: Shares of Sun Pharmaceuticals were under selling pressure and plunged as much as 10.63 per cent in intraday trade as Daiichi Sankyo offloaded its entire stake in the company through ...
 Economic Times1 month ago Sun Pharma cracks 11% as Daiichi exits; should investors buy it?  Economic Times1 month ago
India Infoline

Sale size made Daiichi Sankyo opt for bulk deal

Japanese pharma major Daiichi Sankyo exited Sun Pharma for around $3 billion (nearly Rs 20,000 crore) in what was considered as the biggest ever bulk deal in the history of the Indian markets. So what exactly does a bulk deal constitute, and why did Daiichi ...
 Deccan Herald1 month ago Sun Pharma nosedives, Daiichi's bulk deal major contributor  India Infoline1 month ago

DAIICHI SANKYO : Enters into Distribution Agreement with Kaketsuken

Deal Type: Partnership Deal Sub Type: Co-Marketing Deal Country: Japan Deal Status: Completed Deal Value: 0.0000 USD Deal in Brief Daiichi Sankyo Company, Limited , a pharmaceutical company, has entered into an agreement with ...
 4 Traders4 days ago Daiichi Sankyo's misery ends, block deal gives co the final coup de grĂ¢c  First Post.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - daiichi sankyo
Get updated on latest news & your favorite topics right in your inbox!
More     Less